Find your next paid study

Oncotelic Inc.NCT06079346

~$75 – $2,800

Actual pay is set by the research site.

Patients Scheduled for Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedure

XRAIconnect ERCP - A Single-center Feasibility Study of XRAIconnect Image Guidance Software for ERCP Procedures

The purpose of this research is to establish the usability, feasibility and utility of using XRAIconnect, a software medical device for operative image guidanc…

NYU Langone HealthNCT07841886

~$10 – $1,125

Actual pay is set by the research site.

Smoking CessationSmoking (Tobacco) Addiction

Feasibility of Using a Conversational Agent for Promoting Smoking Cessation Treatment Utilization

The goal of this randomized study is to assess if a conversational agent (or chatbot) that the investigators have developed to help with quitting smoking is ac…

University of MinnesotaNCT07301151

Actual pay is set by the research site.

An Integrative Multi-Omic Characterization of Head and Neck Carcinogenesis, Progression and Recurrence

This study evaluates the cell and biomarkers associated with the aggressive behavior of cancer.

Head and Neck Carcinoma

University of Southern CaliforniaNCT06420219

Actual pay is set by the research site.

Attention Deficit Hyperactivity Disorder (ADHD)

The Investigation of a Mindfulness-Based Intervention for ADHD

Attention-deficit/hyperactivity disorder (ADHD) affects approximately 11% of children and adolescents in the United States. Individuals with ADHD experience su…

Boston Children's HospitalNCT07037030

Actual pay is set by the research site.

Phase 2

TPG: a Phase 2 Trial of Polatuzumab Vedotin, Glofitamab, and Tafasitamab as Chemotherapy-sparing First-line Therapy for Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma

This is a single-center, phase 2, open-label clinical trial of a novel combination of polatuzumab vedotin, glofitamab, and tafasitamab (TPG) as first-line trea…

Diffuse Large B Cell LymphomaHigh-grade B-cell LymphomaLymphoma+1 more

Brown UniversityNCT07502872

~$75 – $2,000

Actual pay is set by the research site.

Phase 3

A Phase 3, Randomized, Double-Blind, Placebo-controlled, Efficacy and Safety Study of Pitolisant Followed by an Open-Label Extension in Patients With Prader-Willi Syndrome

This is a Phase 3, randomized, double-blind, placebo-controlled, multicenter, global clinical study to assess the efficacy and safety of pitolisant in patients…

Prader-Willi Syndrome

Harmony Biosciences Management, Inc.NCT06366464

~$50 – $2,100

Actual pay is set by the research site.

Phase 1

INSIGHT MRL: INtegrating Biology for Safe Intensification of Glioblastoma Hypofractionated Treatment on the MR-Linac

This is a phase 1 study to examine the safety and tolerability of biology-guided dose intensified hypofractionated radiation therapy (RT) using MR-Linac for pa…

High-grade Glioma

NYU Langone HealthNCT07457307

~$150 – $4,500

Actual pay is set by the research site.

Neurogenic BladderMultiple SclerosisOveractive Bladder

A Randomized, Sham-Controlled Clinical Trial Evaluating Individualized Neuromodulation of Cortical Regions Involved in Neurogenic Overactive Bladder in Multiple Sclerosis

Neurogenic overactive bladder (NOAB), characterized by urinary frequency, urgency or urgency incontinence symptoms occurring during the storage phase of the bl…

The Methodist Hospital Research InstituteNCT06072703

Actual pay is set by the research site.

Molecular and Genomic Profiling of Head and Neck Tumors to Explore Biomarkers Associated With Prognosis and Response to Therapy

The purpose of this study is to study the genetic profile of head and neck tumors and their relationship to treatment response and outcome

Head and Neck Neoplasms

Montefiore Medical CenterNCT00200486

Actual pay is set by the research site.

Phase 4

A Pharmaco-Imaging Trial of Mixed Amphetamine Salts for the Treatment of ADHD in Intellectually-intact Youth With Autism Spectrum Disorder

The investigators are conducting a 10-week brain imaging and medication study. They are doing the research to study the response of Attention-Deficit/ Hyperact…

Attention Deficit Hyperactivity Disorder (ADHD)AutismAutism Spectrum Disorder

Pancreatic Cancer MetastaticPancreatic Ductal AdenocarcinomaPancreatic Cancer Stage IV

~$25 – $1,400

Actual pay is set by the research site.

Gagan JoshiNCT06853665

Phase 2

A Randomized, Double-Blind, Placebo-Controlled Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Subjects Previously Untreated for Metastatic Pancreatic Ductal Adenocarcinoma

The study is a randomized, double-blind, placebo-controlled, multicenter study of standard treatment with nab-paclitaxel and gemcitabine with or without SBP-10…